| Literature DB >> 26957741 |
Congqiang Rao1, Liling Xiao1, Hongwei Liu1, Shenghong Li1, Jinqiang Lu1, Jiangxuan Li1, Shixing Gu1.
Abstract
[Purpose] This study evaluated the effects of topical oxygen therapy on the hind limb wounds of rats under ischemic conditions.Entities:
Keywords: Animal model; Topical oxygen therapy; Wound healing
Year: 2016 PMID: 26957741 PMCID: PMC4755987 DOI: 10.1589/jpts.28.118
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.A rat with the topical oxygen device on a limb The device supplied 100% oxygen at 1 atm of pressure
Fig. 2.Typical macroscopic results showing that the wounds of the oxygen group healed faster than those of the control group
Comparison of the wound healing rate
| Day 3 | Day 7 | Day 10 | Day 14 | |
|---|---|---|---|---|
| Control group (n=6) | 45.1±1.9 | 79.4±2.1 | 87.8±1.4 | 97.8±1.5 |
| Treated group (n=6) | 37.3±4.4** | 74.0±2.5** | 85.6±2.7 | 94.5±2.8* |
Values are presented as the mean±SD.
Tested by independent-samples t-test (*p<0.05; **p<0.01)
Treated group: topical oxygen therapy
Comparison of wound healing time
| Group | Healing time |
|---|---|
| Control group | 12.8±0.6 |
| Treated group | 14.7±0.8* |
Values are presented as the mean±SD. Tested by independent-samples t-test (*p<0.05). Treated group: topical oxygen therapy
Fig. 3.HE staining showed that the granulation tissues grew better in the TOT group than the model control group. On days 7–10, the inflammatory cells decreased in the TOT group; however, there were still large numbers of inflammatory cells in the control group
Fig. 4.Collagen fibers in the wounds. On day 7, there were many more collagen fibers in the TOT group
Fig. 5.The expression of CD31 showed that on day 7, there were many more new vessels in the TOT group than the model control group; however, on days 10-14, there were no significant differences between the two groups
Immunohistochemical reaction of CD31 in the wound
| Day 7 | Day 10 | Day 14 | |
|---|---|---|---|
| Control group | ++ | +++ | ++ |
| Treated group | ++++ | +++ | + |